SLDB
NASDAQStockSolid Biosciences Inc.
$7.17-0.54 (-7.00%)
52-Week Range
$2.52
$8.18
Key Stats
Market Cap
558.6M
P/E Ratio
—
Dividend Yield
—
Beta
2.76
Volume
1.4M
Avg Volume
1.8M
Performance
1M
+24.56%
3M
+35.03%
6M
+42.51%
YTD
+41.47%
1Y
+43.84%
3Y
+66.88%
5Y
-92.01%
Price Chart
ETF Exposure
SLDB is held by 51 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | 0.61% |
| MNTL | Tema Neuroscience And Mental Health ETF | 0.57% |
| IWC | iShares Micro-Cap ETF | 0.09% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.08% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.06% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.05% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
Page 1 of 2Next
About SLDB ETF Exposure
Solid Biosciences Inc. (SLDB) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 558.6M, SLDB is a widely held institutional stock. The stock currently trades at $7.17. Investors can gain exposure to SLDB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SLDB, sorted by portfolio weight.